skip navigation


Abstract Database

Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

To download this abstract, check the box next to the NCJ number then click the "Back To Search Results" link. Then, click the "Download" button on the Search Results page. Also see the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 210976 Find in a Library
Title: Brief Overview of the Clinical Pharmacology of "Club Drugs"
Journal: Substance Use and Misuse  Volume:40  Issue:9-10  Dated:2005  Pages:1189-1201
Author(s): Gena Covell Britt; Elinore F. McCance-Katz
Date Published: 2005
Page Count: 13
Type: Report (Study/Research)
Format: Article
Language: English
Country: United States of America
Annotation: This article reviews and briefly summarizes up-to-date literature on the clinical pharmacology of four “club drugs”: MDMA, GHB, ketamine, and Rohypnol.
Abstract: The term “club drugs” refers to a group of drugs used primarily by young adults often at all night dance parties, called “raves” that take place in nightclubs. The United States Department of Justice, Office of National Drug Control Policy (ONDCP) identifies four specific club drugs: MDMA (methylenedioxymethamphetamine, “ecstasy”), GHB (gamma-hydroxybutyrate), ketamine, and Rohypnol (flunitrazepam). This article briefly summarizes current literature on the clinical pharmacology of these four “club drugs” related to humans. The article reviews three areas for each drug: neurobiology, clinical pharmacology, and treatment. Club drugs encompass a variety of medications in several different drug classes. One of the challenges presented by club drugs is the changing face of the “club drug” environment which is associated with the use of multiple drugs and new drugs that defy the development of specific interventions. The gaps in literature are due to the nature of researching substance misuse. It is suggested that future research continue to develop creative ways to investigate outcomes and treatments related to this problem that disproportionately affects youth. References
Main Term(s): Designer drugs
Index Term(s): Acquaintance rape; Controlled Substances; Drug abuse; Drug research; GHB (gammahydroxybutyrate); MDMA (designer drug)
Note: Special Issue on Club Drug Epidemiology
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.